Laura Collie, MD, BS

Juravinski Cancer Center

Hamilton, ON

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 29

3251 - Dosimetric Outcomes of Cytoreductive Stereotactic Body Radiotherapy (SBRT) for Metastatic Renal Cell Carcinoma (mRCC): Data from the CYTOSHRINK Trial

02:15pm - 03:30pm ET